| 1 | york | 2,143 |
| 2 | zealand | 1,640 |
| 3 | jersey | 215 |
| 4 | hampshire | 52 |
| 5 | haven | 37 |
| 6 | orleans | 28 |
| 7 | brunswick | 23 |
| 8 | caledonia | 19 |
| 9 | guinean | 16 |
| 10 | tro-cta | 9 |
| 11 | foundation/american | 7 |
| 12 | zealanders | 7 |
| 13 | millenium | 6 |
| 14 | nbc-bdu | 6 |
| 15 | ninh | 6 |
| 16 | syndesmophytes | 6 |
| 17 | fundamentalism | 5 |
| 18 | caledonia/20/99 | 4 |
| 19 | cpv-2a/2b | 3 |
| 20 | documentation-based | 3 |
| 21 | ics/iuga | 3 |
| 22 | microdeletional | 3 |
| 23 | moxibustion-massage | 3 |
| 24 | nine-needle | 3 |
| 25 | self-sequential | 3 |
| 26 | tomocomd-cardd | 3 |
| 27 | trichomonacide | 3 |
| 28 | 1,3,4-oxadiazole-containing | 2 |
| 29 | 1h-indazoles | 2 |
| 30 | 30/.06 | 2 |
| 31 | 4-product | 2 |
| 32 | azaphilones | 2 |
| 33 | contenders | 2 |
| 34 | coumarin-glycoside | 2 |
| 35 | cpv-2a | 2 |
| 36 | disease-syndrome-symptom | 2 |
| 37 | iv-pensioners | 2 |
| 38 | labdanes | 2 |
| 39 | landrace/large | 2 |
| 40 | lu9 | 2 |
| 41 | medicine/hemostasis | 2 |
| 42 | non-hq-containing | 2 |
| 43 | organic-organic | 2 |
| 44 | pre-pause | 2 |
| 45 | pseudo-ms | 2 |
| 46 | semisythetic | 2 |
| 47 | t1gd | 2 |
| 48 | twelve-membered | 2 |
| 49 | viscosupplement | 2 |
| 50 | york-based | 2 |
| 51 | york-presbyterian | 2 |
| 52 | zeland | 2 |
| 53 | 'class/command | 1 |
| 54 | 'one-pot | 1 |
| 55 | 'smartphone | 1 |
| 56 | -findings | 1 |
| 57 | 1,2-furanonaphthoquinones | 1 |
| 58 | 1,3-diazaphenoxazine | 1 |
| 59 | 1,3-dihydro-3-hydroxy-3- | 1 |
| 60 | 1,5-diaryl-3- | 1 |
| 61 | 12-3-12 | 1 |
| 62 | 14-3-3-predictors | 1 |
| 63 | 14-electron | 1 |
| 64 | 19f-labeled | 1 |
| 65 | 2,3-difunctionalized | 1 |
| 66 | 2,3-dihalo- | 1 |
| 67 | 2,6-di-tert-butyl-4- | 1 |
| 68 | 2-azolyl-3,4-dihydroquinazolines | 1 |
| 69 | 2-hydroxy-1,4-oxazin-3-ones | 1 |
| 70 | 2-methyl-5-nitroimidazoles | 1 |
| 71 | 20-mg/ml | 1 |
| 72 | 3,5-diacetyl-1,2,4-triazol | 1 |
| 73 | 3-acetyl-4-phenyl-3,4-dihydroisocoumarins | 1 |
| 74 | 3-hydroxy-3-methyl-glutaryl-coenzyme-a | 1 |
| 75 | 3-methyl-2-phenylbenzofuran | 1 |
| 76 | 3-o-alkyl-4a,10a-dihydrofusarubins | 1 |
| 77 | 3-substituted-7- | 1 |
| 78 | 30-cm-long | 1 |
| 79 | 4-allyl-2,5-dimethoxyphenol-1-beta-d-glucoside | 1 |
| 80 | 4-amino-1,2,4-triazole | 1 |
| 81 | 48-page | 1 |
| 82 | 7-piperazinyl | 1 |
| 83 | 8-contact | 1 |
| 84 | 9-alkyl-5- | 1 |
| 85 | acylresorcinol | 1 |
| 86 | agents-leflunomide | 1 |
| 87 | akh/red | 1 |
| 88 | alkylator-free | 1 |
| 89 | angiotensin-ii-antagonist | 1 |
| 90 | anti-acetylcholinesterase | 1 |
| 91 | anti-cd30-toxin-drug-conjugate | 1 |
| 92 | antibody-capture | 1 |
| 93 | antikinetoplastid | 1 |
| 94 | antimicrotubules | 1 |
| 95 | anti‑immunoglobulin | 1 |
| 96 | aqua-soluble | 1 |
| 97 | auto-digestion | 1 |
| 98 | bakkenolides | 1 |
| 99 | biogeometric | 1 |
| 100 | biopolymeric | 1 |
| 101 | birth-rate | 1 |
| 102 | bolus-constant | 1 |
| 103 | bone-to-implant-contact | 1 |
| 104 | bone-volume-per-tissue-volume | 1 |
| 105 | bpd-diagnoses | 1 |
| 106 | bronchopulmonary-dysplasia | 1 |
| 107 | bronchosecretolytic | 1 |
| 108 | bypass-occlusion | 1 |
| 109 | caledonia/4/83 | 1 |
| 110 | californium | 1 |
| 111 | cams-related | 1 |
| 112 | care-delivering | 1 |
| 113 | cases.one | 1 |
| 114 | ccsvi-positive | 1 |
| 115 | cdc/aap/acog | 1 |
| 116 | cefamicin | 1 |
| 117 | cholesterolol | 1 |
| 118 | cis-palladium | 1 |
| 119 | clausidiid | 1 |
| 120 | colloidosome | 1 |
| 121 | concept-mapping | 1 |
| 122 | construction/remodeling | 1 |
| 123 | cottontail | 1 |
| 124 | criteria/areas | 1 |
| 125 | culturestat | 1 |
| 126 | cycloheptadibenzofuran | 1 |
| 127 | d-π-a'-π-a | 1 |
| 128 | dammarane-glycoside | 1 |
| 129 | dehli | 1 |
| 130 | demineralization/remineralization | 1 |
| 131 | depot-bromocriptine | 1 |
| 132 | discipline-network | 1 |
| 133 | disease-epidemiological | 1 |
| 134 | documentation- | 1 |
| 135 | donor-acceptor'-acceptor-type | 1 |
| 136 | drugfile | 1 |
| 137 | e600 | 1 |
| 138 | echo-method | 1 |
| 139 | eclinical | 1 |
| 140 | egfr-formulas | 1 |
| 141 | esophagostomy | 1 |
| 142 | extragynecological | 1 |
| 143 | fitc-quencher | 1 |
| 144 | flutter-type | 1 |
| 145 | fog-questionnaire | 1 |
| 146 | francisella-like | 1 |
| 147 | full-beam | 1 |
| 148 | genomic-ssrs | 1 |
| 149 | gestogen | 1 |
| 150 | guinea/irian | 1 |
| 151 | h3.1-h | 1 |
| 152 | heroin-provision | 1 |
| 153 | home-scale | 1 |
| 154 | hsf-foxm1 | 1 |
| 155 | hxny | 1 |
| 156 | hydroperoxo-ferriheme | 1 |
| 157 | ichnotaxon | 1 |
| 158 | ii/iii/iv | 1 |
| 159 | inflammation/no | 1 |
| 160 | insulin-intercalated | 1 |
| 161 | ipf-guideline | 1 |
| 162 | isomerous | 1 |
| 163 | kaolin-based | 1 |
| 164 | l0d2c | 1 |
| 165 | ldl-receptor-mutation | 1 |
| 166 | lecithin/silver | 1 |
| 167 | ledtech | 1 |
| 168 | low-monomer | 1 |
| 169 | lrk | 1 |
| 170 | lvmdp-based | 1 |
| 171 | magnetic-guided | 1 |
| 172 | meal-photo | 1 |
| 173 | meso-substituted | 1 |
| 174 | microbubble-based | 1 |
| 175 | middle-grade | 1 |
| 176 | mtabased | 1 |
| 177 | n-methylimidazole | 1 |
| 178 | n-substituted-3,5-bis | 1 |
| 179 | n2-p3 | 1 |
| 180 | n3o | 1 |
| 181 | naucorid | 1 |
| 182 | ncepatp-iii | 1 |
| 183 | nicotinonitriles | 1 |
| 184 | non-extra | 1 |
| 185 | non-recrudescent | 1 |
| 186 | nortriterpenes | 1 |
| 187 | norway-lewis | 1 |
| 188 | nvp-resistance | 1 |
| 189 | o-prenylated | 1 |
| 190 | octaketide | 1 |
| 191 | ofischemic | 1 |
| 192 | oligophosphane | 1 |
| 193 | oligostilbene | 1 |
| 194 | once-a | 1 |
| 195 | ooe | 1 |
| 196 | orally-effective | 1 |
| 197 | organization-established | 1 |
| 198 | oxacillinase | 1 |
| 199 | pacinginduced | 1 |
| 200 | para-phenyl | 1 |
| 201 | persectives | 1 |
| 202 | pharmaco-policy | 1 |
| 203 | phylogram | 1 |
| 204 | phytoformula | 1 |
| 205 | picco-algorithm | 1 |
| 206 | pla/peg-ppg-peg/dexamethasone | 1 |
| 207 | pmma/fe | 1 |
| 208 | po-free | 1 |
| 209 | polyfiber | 1 |
| 210 | prenylisoflavones | 1 |
| 211 | pressure/resting | 1 |
| 212 | prl-3-dependent | 1 |
| 213 | procedure-single-incision | 1 |
| 214 | program/american | 1 |
| 215 | protocol.our | 1 |
| 216 | pseudopolymorph | 1 |
| 217 | psolaren | 1 |
| 218 | pyranoflavonoids | 1 |
| 219 | pyridine-pyrazole | 1 |
| 220 | pyrrolocarbazoles | 1 |
| 221 | quasi-podands | 1 |
| 222 | quinoline- | 1 |
| 223 | quinoline-2 | 1 |
| 224 | rapid-job-placement | 1 |
| 225 | razorblade | 1 |
| 226 | rct-data | 1 |
| 227 | reactor-like | 1 |
| 228 | remineralization/demineralization | 1 |
| 229 | sac-shaped | 1 |
| 230 | salicylideneimine-functionalized | 1 |
| 231 | sarver | 1 |
| 232 | scalloping/new | 1 |
| 233 | scc/year | 1 |
| 234 | sensitisations | 1 |
| 235 | size-expected | 1 |
| 236 | soicr-inhibiting | 1 |
| 237 | species-caryospora | 1 |
| 238 | stent-graft-based | 1 |
| 239 | stressless | 1 |
| 240 | studies.all | 1 |
| 241 | subacute-phase | 1 |
| 242 | surface/interface | 1 |
| 243 | tachypaced | 1 |
| 244 | tcm-decoction | 1 |
| 245 | technology/opportunity | 1 |
| 246 | temperature-perturbed | 1 |
| 247 | tetrahydrotriazine-containing | 1 |
| 248 | thiazeto-quinoline | 1 |
| 249 | thrombolytic-3 | 1 |
| 250 | transmucosal/buccal | 1 |
| 251 | treatment/favouring | 1 |
| 252 | treatmentapproaches | 1 |
| 253 | trichomonasviruses | 1 |
| 254 | truliner | 1 |
| 255 | truliner-n | 1 |
| 256 | tumour-reactive | 1 |
| 257 | ultra-short-lived | 1 |
| 258 | uroobstruction | 1 |
| 259 | video-projected | 1 |
| 260 | water-uptake | 1 |
| 261 | xylo-oligosaccharide | 1 |
| 262 | york/new | 1 |
| 263 | yorkers | 1 |
| 264 | yourk | 1 |
| 265 | zealander | 1 |
| 266 | α-tetralone | 1 |
| 1 | 'class/command | 1 |
| 2 | 'one-pot | 1 |
| 3 | 'smartphone | 1 |
| 4 | -findings | 1 |
| 5 | 1,2-furanonaphthoquinones | 1 |
| 6 | 1,3,4-oxadiazole-containing | 2 |
| 7 | 1,3-diazaphenoxazine | 1 |
| 8 | 1,3-dihydro-3-hydroxy-3- | 1 |
| 9 | 1,5-diaryl-3- | 1 |
| 10 | 12-3-12 | 1 |
| 11 | 14-3-3-predictors | 1 |
| 12 | 14-electron | 1 |
| 13 | 19f-labeled | 1 |
| 14 | 1h-indazoles | 2 |
| 15 | 2,3-difunctionalized | 1 |
| 16 | 2,3-dihalo- | 1 |
| 17 | 2,6-di-tert-butyl-4- | 1 |
| 18 | 2-azolyl-3,4-dihydroquinazolines | 1 |
| 19 | 2-hydroxy-1,4-oxazin-3-ones | 1 |
| 20 | 2-methyl-5-nitroimidazoles | 1 |
| 21 | 20-mg/ml | 1 |
| 22 | 3,5-diacetyl-1,2,4-triazol | 1 |
| 23 | 3-acetyl-4-phenyl-3,4-dihydroisocoumarins | 1 |
| 24 | 3-hydroxy-3-methyl-glutaryl-coenzyme-a | 1 |
| 25 | 3-methyl-2-phenylbenzofuran | 1 |
| 26 | 3-o-alkyl-4a,10a-dihydrofusarubins | 1 |
| 27 | 3-substituted-7- | 1 |
| 28 | 30-cm-long | 1 |
| 29 | 30/.06 | 2 |
| 30 | 4-allyl-2,5-dimethoxyphenol-1-beta-d-glucoside | 1 |
| 31 | 4-amino-1,2,4-triazole | 1 |
| 32 | 4-product | 2 |
| 33 | 48-page | 1 |
| 34 | 7-piperazinyl | 1 |
| 35 | 8-contact | 1 |
| 36 | 9-alkyl-5- | 1 |
| 37 | acylresorcinol | 1 |
| 38 | agents-leflunomide | 1 |
| 39 | akh/red | 1 |
| 40 | alkylator-free | 1 |
| 41 | angiotensin-ii-antagonist | 1 |
| 42 | anti-acetylcholinesterase | 1 |
| 43 | anti-cd30-toxin-drug-conjugate | 1 |
| 44 | antibody-capture | 1 |
| 45 | antikinetoplastid | 1 |
| 46 | antimicrotubules | 1 |
| 47 | anti‑immunoglobulin | 1 |
| 48 | aqua-soluble | 1 |
| 49 | auto-digestion | 1 |
| 50 | azaphilones | 2 |
| 51 | bakkenolides | 1 |
| 52 | biogeometric | 1 |
| 53 | biopolymeric | 1 |
| 54 | birth-rate | 1 |
| 55 | bolus-constant | 1 |
| 56 | bone-to-implant-contact | 1 |
| 57 | bone-volume-per-tissue-volume | 1 |
| 58 | bpd-diagnoses | 1 |
| 59 | bronchopulmonary-dysplasia | 1 |
| 60 | bronchosecretolytic | 1 |
| 61 | brunswick | 23 |
| 62 | bypass-occlusion | 1 |
| 63 | caledonia | 19 |
| 64 | caledonia/20/99 | 4 |
| 65 | caledonia/4/83 | 1 |
| 66 | californium | 1 |
| 67 | cams-related | 1 |
| 68 | care-delivering | 1 |
| 69 | cases.one | 1 |
| 70 | ccsvi-positive | 1 |
| 71 | cdc/aap/acog | 1 |
| 72 | cefamicin | 1 |
| 73 | cholesterolol | 1 |
| 74 | cis-palladium | 1 |
| 75 | clausidiid | 1 |
| 76 | colloidosome | 1 |
| 77 | concept-mapping | 1 |
| 78 | construction/remodeling | 1 |
| 79 | contenders | 2 |
| 80 | cottontail | 1 |
| 81 | coumarin-glycoside | 2 |
| 82 | cpv-2a | 2 |
| 83 | cpv-2a/2b | 3 |
| 84 | criteria/areas | 1 |
| 85 | culturestat | 1 |
| 86 | cycloheptadibenzofuran | 1 |
| 87 | d-π-a'-π-a | 1 |
| 88 | dammarane-glycoside | 1 |
| 89 | dehli | 1 |
| 90 | demineralization/remineralization | 1 |
| 91 | depot-bromocriptine | 1 |
| 92 | discipline-network | 1 |
| 93 | disease-epidemiological | 1 |
| 94 | disease-syndrome-symptom | 2 |
| 95 | documentation- | 1 |
| 96 | documentation-based | 3 |
| 97 | donor-acceptor'-acceptor-type | 1 |
| 98 | drugfile | 1 |
| 99 | e600 | 1 |
| 100 | echo-method | 1 |
| 101 | eclinical | 1 |
| 102 | egfr-formulas | 1 |
| 103 | esophagostomy | 1 |
| 104 | extragynecological | 1 |
| 105 | fitc-quencher | 1 |
| 106 | flutter-type | 1 |
| 107 | fog-questionnaire | 1 |
| 108 | foundation/american | 7 |
| 109 | francisella-like | 1 |
| 110 | full-beam | 1 |
| 111 | fundamentalism | 5 |
| 112 | genomic-ssrs | 1 |
| 113 | gestogen | 1 |
| 114 | guinea/irian | 1 |
| 115 | guinean | 16 |
| 116 | h3.1-h | 1 |
| 117 | hampshire | 52 |
| 118 | haven | 37 |
| 119 | heroin-provision | 1 |
| 120 | home-scale | 1 |
| 121 | hsf-foxm1 | 1 |
| 122 | hxny | 1 |
| 123 | hydroperoxo-ferriheme | 1 |
| 124 | ichnotaxon | 1 |
| 125 | ics/iuga | 3 |
| 126 | ii/iii/iv | 1 |
| 127 | inflammation/no | 1 |
| 128 | insulin-intercalated | 1 |
| 129 | ipf-guideline | 1 |
| 130 | isomerous | 1 |
| 131 | iv-pensioners | 2 |
| 132 | jersey | 215 |
| 133 | kaolin-based | 1 |
| 134 | l0d2c | 1 |
| 135 | labdanes | 2 |
| 136 | landrace/large | 2 |
| 137 | ldl-receptor-mutation | 1 |
| 138 | lecithin/silver | 1 |
| 139 | ledtech | 1 |
| 140 | low-monomer | 1 |
| 141 | lrk | 1 |
| 142 | lu9 | 2 |
| 143 | lvmdp-based | 1 |
| 144 | magnetic-guided | 1 |
| 145 | meal-photo | 1 |
| 146 | medicine/hemostasis | 2 |
| 147 | meso-substituted | 1 |
| 148 | microbubble-based | 1 |
| 149 | microdeletional | 3 |
| 150 | middle-grade | 1 |
| 151 | millenium | 6 |
| 152 | moxibustion-massage | 3 |
| 153 | mtabased | 1 |
| 154 | n-methylimidazole | 1 |
| 155 | n-substituted-3,5-bis | 1 |
| 156 | n2-p3 | 1 |
| 157 | n3o | 1 |
| 158 | naucorid | 1 |
| 159 | nbc-bdu | 6 |
| 160 | ncepatp-iii | 1 |
| 161 | nicotinonitriles | 1 |
| 162 | nine-needle | 3 |
| 163 | ninh | 6 |
| 164 | non-extra | 1 |
| 165 | non-hq-containing | 2 |
| 166 | non-recrudescent | 1 |
| 167 | nortriterpenes | 1 |
| 168 | norway-lewis | 1 |
| 169 | nvp-resistance | 1 |
| 170 | o-prenylated | 1 |
| 171 | octaketide | 1 |
| 172 | ofischemic | 1 |
| 173 | oligophosphane | 1 |
| 174 | oligostilbene | 1 |
| 175 | once-a | 1 |
| 176 | ooe | 1 |
| 177 | orally-effective | 1 |
| 178 | organic-organic | 2 |
| 179 | organization-established | 1 |
| 180 | orleans | 28 |
| 181 | oxacillinase | 1 |
| 182 | pacinginduced | 1 |
| 183 | para-phenyl | 1 |
| 184 | persectives | 1 |
| 185 | pharmaco-policy | 1 |
| 186 | phylogram | 1 |
| 187 | phytoformula | 1 |
| 188 | picco-algorithm | 1 |
| 189 | pla/peg-ppg-peg/dexamethasone | 1 |
| 190 | pmma/fe | 1 |
| 191 | po-free | 1 |
| 192 | polyfiber | 1 |
| 193 | pre-pause | 2 |
| 194 | prenylisoflavones | 1 |
| 195 | pressure/resting | 1 |
| 196 | prl-3-dependent | 1 |
| 197 | procedure-single-incision | 1 |
| 198 | program/american | 1 |
| 199 | protocol.our | 1 |
| 200 | pseudo-ms | 2 |
| 201 | pseudopolymorph | 1 |
| 202 | psolaren | 1 |
| 203 | pyranoflavonoids | 1 |
| 204 | pyridine-pyrazole | 1 |
| 205 | pyrrolocarbazoles | 1 |
| 206 | quasi-podands | 1 |
| 207 | quinoline- | 1 |
| 208 | quinoline-2 | 1 |
| 209 | rapid-job-placement | 1 |
| 210 | razorblade | 1 |
| 211 | rct-data | 1 |
| 212 | reactor-like | 1 |
| 213 | remineralization/demineralization | 1 |
| 214 | sac-shaped | 1 |
| 215 | salicylideneimine-functionalized | 1 |
| 216 | sarver | 1 |
| 217 | scalloping/new | 1 |
| 218 | scc/year | 1 |
| 219 | self-sequential | 3 |
| 220 | semisythetic | 2 |
| 221 | sensitisations | 1 |
| 222 | size-expected | 1 |
| 223 | soicr-inhibiting | 1 |
| 224 | species-caryospora | 1 |
| 225 | stent-graft-based | 1 |
| 226 | stressless | 1 |
| 227 | studies.all | 1 |
| 228 | subacute-phase | 1 |
| 229 | surface/interface | 1 |
| 230 | syndesmophytes | 6 |
| 231 | t1gd | 2 |
| 232 | tachypaced | 1 |
| 233 | tcm-decoction | 1 |
| 234 | technology/opportunity | 1 |
| 235 | temperature-perturbed | 1 |
| 236 | tetrahydrotriazine-containing | 1 |
| 237 | thiazeto-quinoline | 1 |
| 238 | thrombolytic-3 | 1 |
| 239 | tomocomd-cardd | 3 |
| 240 | transmucosal/buccal | 1 |
| 241 | treatment/favouring | 1 |
| 242 | treatmentapproaches | 1 |
| 243 | trichomonacide | 3 |
| 244 | trichomonasviruses | 1 |
| 245 | tro-cta | 9 |
| 246 | truliner | 1 |
| 247 | truliner-n | 1 |
| 248 | tumour-reactive | 1 |
| 249 | twelve-membered | 2 |
| 250 | ultra-short-lived | 1 |
| 251 | uroobstruction | 1 |
| 252 | video-projected | 1 |
| 253 | viscosupplement | 2 |
| 254 | water-uptake | 1 |
| 255 | xylo-oligosaccharide | 1 |
| 256 | york | 2,143 |
| 257 | york-based | 2 |
| 258 | york-presbyterian | 2 |
| 259 | york/new | 1 |
| 260 | yorkers | 1 |
| 261 | yourk | 1 |
| 262 | zealand | 1,640 |
| 263 | zealander | 1 |
| 264 | zealanders | 7 |
| 265 | zeland | 2 |
| 266 | α-tetralone | 1 |
| 1 | 1,5-diaryl-3- | 1 |
| 2 | 1,3-dihydro-3-hydroxy-3- | 1 |
| 3 | 2,6-di-tert-butyl-4- | 1 |
| 4 | 9-alkyl-5- | 1 |
| 5 | 3-substituted-7- | 1 |
| 6 | quinoline- | 1 |
| 7 | documentation- | 1 |
| 8 | 2,3-dihalo- | 1 |
| 9 | e600 | 1 |
| 10 | hsf-foxm1 | 1 |
| 11 | quinoline-2 | 1 |
| 12 | 12-3-12 | 1 |
| 13 | thrombolytic-3 | 1 |
| 14 | caledonia/4/83 | 1 |
| 15 | n2-p3 | 1 |
| 16 | 30/.06 | 2 |
| 17 | caledonia/20/99 | 4 |
| 18 | lu9 | 2 |
| 19 | once-a | 1 |
| 20 | 3-hydroxy-3-methyl-glutaryl-coenzyme-a | 1 |
| 21 | d-π-a'-π-a | 1 |
| 22 | cpv-2a | 2 |
| 23 | ics/iuga | 3 |
| 24 | caledonia | 19 |
| 25 | bronchopulmonary-dysplasia | 1 |
| 26 | phytoformula | 1 |
| 27 | species-caryospora | 1 |
| 28 | non-extra | 1 |
| 29 | rct-data | 1 |
| 30 | tro-cta | 9 |
| 31 | cpv-2a/2b | 3 |
| 32 | l0d2c | 1 |
| 33 | ofischemic | 1 |
| 34 | organic-organic | 2 |
| 35 | biopolymeric | 1 |
| 36 | biogeometric | 1 |
| 37 | semisythetic | 2 |
| 38 | bronchosecretolytic | 1 |
| 39 | tomocomd-cardd | 3 |
| 40 | temperature-perturbed | 1 |
| 41 | tachypaced | 1 |
| 42 | pacinginduced | 1 |
| 43 | magnetic-guided | 1 |
| 44 | organization-established | 1 |
| 45 | 19f-labeled | 1 |
| 46 | sac-shaped | 1 |
| 47 | akh/red | 1 |
| 48 | twelve-membered | 2 |
| 49 | microbubble-based | 1 |
| 50 | york-based | 2 |
| 51 | kaolin-based | 1 |
| 52 | documentation-based | 3 |
| 53 | lvmdp-based | 1 |
| 54 | stent-graft-based | 1 |
| 55 | mtabased | 1 |
| 56 | insulin-intercalated | 1 |
| 57 | cams-related | 1 |
| 58 | o-prenylated | 1 |
| 59 | video-projected | 1 |
| 60 | size-expected | 1 |
| 61 | meso-substituted | 1 |
| 62 | ultra-short-lived | 1 |
| 63 | salicylideneimine-functionalized | 1 |
| 64 | 2,3-difunctionalized | 1 |
| 65 | t1gd | 2 |
| 66 | clausidiid | 1 |
| 67 | naucorid | 1 |
| 68 | antikinetoplastid | 1 |
| 69 | zealand | 1,640 |
| 70 | zeland | 2 |
| 71 | 'class/command | 1 |
| 72 | echo-method | 1 |
| 73 | surface/interface | 1 |
| 74 | nvp-resistance | 1 |
| 75 | razorblade | 1 |
| 76 | middle-grade | 1 |
| 77 | trichomonacide | 3 |
| 78 | agents-leflunomide | 1 |
| 79 | xylo-oligosaccharide | 1 |
| 80 | 4-allyl-2,5-dimethoxyphenol-1-beta-d-glucoside | 1 |
| 81 | dammarane-glycoside | 1 |
| 82 | coumarin-glycoside | 2 |
| 83 | octaketide | 1 |
| 84 | po-free | 1 |
| 85 | alkylator-free | 1 |
| 86 | pmma/fe | 1 |
| 87 | 48-page | 1 |
| 88 | moxibustion-massage | 3 |
| 89 | landrace/large | 2 |
| 90 | water-uptake | 1 |
| 91 | francisella-like | 1 |
| 92 | reactor-like | 1 |
| 93 | home-scale | 1 |
| 94 | aqua-soluble | 1 |
| 95 | nine-needle | 3 |
| 96 | drugfile | 1 |
| 97 | n-methylimidazole | 1 |
| 98 | 4-amino-1,2,4-triazole | 1 |
| 99 | pyridine-pyrazole | 1 |
| 100 | hydroperoxo-ferriheme | 1 |
| 101 | colloidosome | 1 |
| 102 | bone-volume-per-tissue-volume | 1 |
| 103 | oligophosphane | 1 |
| 104 | oligostilbene | 1 |
| 105 | ipf-guideline | 1 |
| 106 | thiazeto-quinoline | 1 |
| 107 | depot-bromocriptine | 1 |
| 108 | 1,3-diazaphenoxazine | 1 |
| 109 | cases.one | 1 |
| 110 | 'smartphone | 1 |
| 111 | α-tetralone | 1 |
| 112 | pla/peg-ppg-peg/dexamethasone | 1 |
| 113 | ooe | 1 |
| 114 | flutter-type | 1 |
| 115 | donor-acceptor'-acceptor-type | 1 |
| 116 | fog-questionnaire | 1 |
| 117 | hampshire | 52 |
| 118 | antibody-capture | 1 |
| 119 | subacute-phase | 1 |
| 120 | oxacillinase | 1 |
| 121 | anti-acetylcholinesterase | 1 |
| 122 | pre-pause | 2 |
| 123 | anti-cd30-toxin-drug-conjugate | 1 |
| 124 | birth-rate | 1 |
| 125 | tumour-reactive | 1 |
| 126 | orally-effective | 1 |
| 127 | ccsvi-positive | 1 |
| 128 | construction/remodeling | 1 |
| 129 | 1,3,4-oxadiazole-containing | 2 |
| 130 | tetrahydrotriazine-containing | 1 |
| 131 | non-hq-containing | 2 |
| 132 | concept-mapping | 1 |
| 133 | care-delivering | 1 |
| 134 | treatment/favouring | 1 |
| 135 | soicr-inhibiting | 1 |
| 136 | pressure/resting | 1 |
| 137 | 30-cm-long | 1 |
| 138 | cdc/aap/acog | 1 |
| 139 | h3.1-h | 1 |
| 140 | ledtech | 1 |
| 141 | ninh | 6 |
| 142 | pseudopolymorph | 1 |
| 143 | ncepatp-iii | 1 |
| 144 | dehli | 1 |
| 145 | brunswick | 23 |
| 146 | lrk | 1 |
| 147 | discipline-network | 1 |
| 148 | york | 2,143 |
| 149 | yourk | 1 |
| 150 | transmucosal/buccal | 1 |
| 151 | extragynecological | 1 |
| 152 | disease-epidemiological | 1 |
| 153 | eclinical | 1 |
| 154 | self-sequential | 3 |
| 155 | microdeletional | 3 |
| 156 | cottontail | 1 |
| 157 | studies.all | 1 |
| 158 | 20-mg/ml | 1 |
| 159 | cholesterolol | 1 |
| 160 | acylresorcinol | 1 |
| 161 | 3,5-diacetyl-1,2,4-triazol | 1 |
| 162 | para-phenyl | 1 |
| 163 | 7-piperazinyl | 1 |
| 164 | full-beam | 1 |
| 165 | phylogram | 1 |
| 166 | picco-algorithm | 1 |
| 167 | disease-syndrome-symptom | 2 |
| 168 | fundamentalism | 5 |
| 169 | cis-palladium | 1 |
| 170 | millenium | 6 |
| 171 | californium | 1 |
| 172 | truliner-n | 1 |
| 173 | program/american | 1 |
| 174 | foundation/american | 7 |
| 175 | guinean | 16 |
| 176 | york-presbyterian | 2 |
| 177 | guinea/irian | 1 |
| 178 | cycloheptadibenzofuran | 1 |
| 179 | 3-methyl-2-phenylbenzofuran | 1 |
| 180 | gestogen | 1 |
| 181 | psolaren | 1 |
| 182 | haven | 37 |
| 183 | cefamicin | 1 |
| 184 | anti‑immunoglobulin | 1 |
| 185 | procedure-single-incision | 1 |
| 186 | heroin-provision | 1 |
| 187 | bypass-occlusion | 1 |
| 188 | ldl-receptor-mutation | 1 |
| 189 | remineralization/demineralization | 1 |
| 190 | demineralization/remineralization | 1 |
| 191 | tcm-decoction | 1 |
| 192 | uroobstruction | 1 |
| 193 | auto-digestion | 1 |
| 194 | 14-electron | 1 |
| 195 | ichnotaxon | 1 |
| 196 | n3o | 1 |
| 197 | inflammation/no | 1 |
| 198 | meal-photo | 1 |
| 199 | scc/year | 1 |
| 200 | polyfiber | 1 |
| 201 | zealander | 1 |
| 202 | fitc-quencher | 1 |
| 203 | low-monomer | 1 |
| 204 | truliner | 1 |
| 205 | lecithin/silver | 1 |
| 206 | sarver | 1 |
| 207 | protocol.our | 1 |
| 208 | criteria/areas | 1 |
| 209 | egfr-formulas | 1 |
| 210 | pyranoflavonoids | 1 |
| 211 | quasi-podands | 1 |
| 212 | bakkenolides | 1 |
| 213 | treatmentapproaches | 1 |
| 214 | nicotinonitriles | 1 |
| 215 | pyrrolocarbazoles | 1 |
| 216 | 2-methyl-5-nitroimidazoles | 1 |
| 217 | 1h-indazoles | 2 |
| 218 | antimicrotubules | 1 |
| 219 | labdanes | 2 |
| 220 | nortriterpenes | 1 |
| 221 | 2-azolyl-3,4-dihydroquinazolines | 1 |
| 222 | 2-hydroxy-1,4-oxazin-3-ones | 1 |
| 223 | azaphilones | 2 |
| 224 | 1,2-furanonaphthoquinones | 1 |
| 225 | prenylisoflavones | 1 |
| 226 | bpd-diagnoses | 1 |
| 227 | trichomonasviruses | 1 |
| 228 | syndesmophytes | 6 |
| 229 | persectives | 1 |
| 230 | -findings | 1 |
| 231 | n-substituted-3,5-bis | 1 |
| 232 | medicine/hemostasis | 2 |
| 233 | norway-lewis | 1 |
| 234 | pseudo-ms | 2 |
| 235 | orleans | 28 |
| 236 | 3-o-alkyl-4a,10a-dihydrofusarubins | 1 |
| 237 | 3-acetyl-4-phenyl-3,4-dihydroisocoumarins | 1 |
| 238 | sensitisations | 1 |
| 239 | zealanders | 7 |
| 240 | contenders | 2 |
| 241 | yorkers | 1 |
| 242 | iv-pensioners | 2 |
| 243 | 14-3-3-predictors | 1 |
| 244 | genomic-ssrs | 1 |
| 245 | stressless | 1 |
| 246 | isomerous | 1 |
| 247 | culturestat | 1 |
| 248 | 8-contact | 1 |
| 249 | bone-to-implant-contact | 1 |
| 250 | 4-product | 2 |
| 251 | bolus-constant | 1 |
| 252 | non-recrudescent | 1 |
| 253 | prl-3-dependent | 1 |
| 254 | rapid-job-placement | 1 |
| 255 | viscosupplement | 2 |
| 256 | 'one-pot | 1 |
| 257 | angiotensin-ii-antagonist | 1 |
| 258 | nbc-bdu | 6 |
| 259 | ii/iii/iv | 1 |
| 260 | scalloping/new | 1 |
| 261 | york/new | 1 |
| 262 | pharmaco-policy | 1 |
| 263 | jersey | 215 |
| 264 | esophagostomy | 1 |
| 265 | hxny | 1 |
| 266 | technology/opportunity | 1 |